Abstract
Respiratory tract infections account for high morbidity and mortality around the world. Fragile patients are at high risk of developing complications such as pneumonia and may die from it. Limited information is available on the extent of the circulation of respiratory viruses in the hospital setting. Most knowledge relates to influenza viruses (FLU) but several other viruses produce flu-like illness. The study was conducted at the University Hospital Policlinico Tor Vergata, Rome, Italy. Clinical and laboratory data from hospitalized patients with respiratory tract infections during the period October 2016–March 2019 were analysed. The retrospective analysis included 17 viral agents detected by FilmArray test and clinical data from medical records and hospital discharge sheets. Models were adjusted for relevant confounders such as clinical severity and risk of death, socio-demographic characteristics and surgical procedures. From a total of 539 specimens analysed, 180 (33.39%) were positive for one or more respiratory viruses. Among them, 83 (46.1 %) were positive for influenza viruses (FLU), 36 (20%) rhino/enteroviruses (RHV/EV), 17 (9.44%) human coronaviruses (HCOV-229E, -HKU1, -NL63, and -OC43), 17 (9.44%) respiratory syncytial virus, 15 (8.33%) human metapneumovirus (HMPV), 8 (4.44%) parainfluenza viruses (PIV) and 4 (2.22%) adenoviruses (ADV). The distribution of viral agents varied across age groups and month of detection. The positive specimens were from 168 patients [102 M, 66 F; median age (range): 64 years (19−93)]. Overall, 40% of them had a high-grade clinical severity and a 27% risk of death; 27 patients died and 22 of them (81.5%) had received a clinical diagnosis of pneumonia. Respiratory viral infections may have a severe course and a poor prognosis in hospitalized patients, due to underlying comorbidities. Monitoring the circulation of respiratory viruses in hospital settings is important to improve diagnosis, prevention and treatment.
Highlights
Infections of the respiratory tract are an important cause of morbidity and mortality around the world
Epidemiology, demographic characteristics and the clinical outcome of patients tested positive for the presence of one or more respiratory viruses are discussed
The identified viral agents included all the respiratory viruses commonly circulating in the community as well as in the hospital setting, namely FLU A and B viruses, RHV/EV, human coronaviruses (HCOV), respiratory syncytial virus (RSV), human metapneumovirus (HMPV), parainfluenza viruses (PIV) and ADV, as already reported by other authors [8,9,10]
Summary
Infections of the respiratory tract are an important cause of morbidity and mortality around the world. Haemophilus influenzae type b, Streptococcus pneumoniae, influenza virus and respiratory syncytial virus are the leading causes of lower tract respiratory infections [1]. While global monitoring of influenza viruses is well established and aims at the development of effective seasonal vaccines against the influenza virus, the monitoring of other respiratory viruses is not always well defined and requires implementation [4]. From this point of view, the use of rapid, sensitive, multiplex PCR-based tests which allow a broad-spectrum screening of respiratory viruses has clinical relevance. A rapid diagnosis will avoid the administration of an unnecessary antibiotic therapy as well as a prompt isolation of the infected patient, avoiding the spread of the infectious agent between critically ill patients in intensive care units or onco-hematological wards
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.